22 - CLAP

1093. Muller KM, Berkel HD, Wosiewitz U, Heller K, Dominick HC, Reinhold P. Yellow pulmonary hyalinemembranes. Morphology and pathogenesis. Arch Anat Cytol Pathol. 1980;28(5):283-5.1094. Narang A, Kumar P, Dutta S, Kumar R. Surfactant therapy for hyaline membrane disease: the Chandigarhexperience. Indian Pediatr. 2001 Jun;38(6):640-6.1095. No authors listed. Hyaline membrane disease. N Y State J Med. 1971 Apr 15;71(8):872-5.1096. Patil BM, Sane SY. Pathology of hyaline membrane disease in neonates. Indian J Pathol Microbiol.1983 Jul;26(3):209-12.1097. Perlman M, Kirpalani HM, Moore AM. Residents Handbook of Neonatology. 2d Ed. BC Decker Inc.Saint Louis, 1999.1098. Rossello JD, Hayward PE, Martell M, et alHyaline membrane disease (HMD) therapy in Latin America:impact of exogenous surfactant administration on newborn survival, morbidity and use of resources. JPerinat Med. 1997;25(3):280-7.1099. Rubaltelli FF, Bonafe L, Tangucci M, Spagnolo A, Dani C. Epidemiology of neonatal acute respiratorydisorders. A multicenter study on incidence and fatality rates of neonatal acute respiratory disordersaccording to gestational age, maternal age, pregnancy complications and type of delivery. Italian Groupof Neonatal Pneumology. Biol Neonate. 1998;74(1):7-15.1100. Smith BT,Worthington D, Maloney AH. Fetal lung maturation. III.The amniotic fluid cortisol/cortisoneratio in preterm human delivery and the risk of respiratory distress syndrome. Obstet Gynecol. 1977May;49(5):527-31.1101. Whittle MJ,Wilson AI,Whitfield CR. Amniotic fluid phosphatidylglycerol: an early indicator of fetallung maturity. Br J Obstet Gynaecol. 1983 Feb;90(2):134-8.1102. Wolfson SL, Frech R, Hewitt C, Shanklin DR. Radiographic diagnosis of hyaline membrane disease.Radiology. 1969 Aug;93(2):339-43.1103. Zakia S,Talib VH, Kshirsagar VH, Patil SD, Deshpande MS, Sharma KD. Hyaline membrane disease inthe newborn. Indian Pediatr. 1973 Dec;10(12):701-5.Neumonía perinatal1104. Christensen KK, Christensen P, Dahlander K, Linden V, Lindroth M, Svenningsen N. The significance ofgroup B streptococci in neonatal pneumonia. Eur J Pediatr. 1983 Apr;140(2):118-22.1105. Engle WD, Jackson GL, Sendelbach D, et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotictherapy in term and near-term infants. J Perinatol. 2000 Oct-Nov;20(7):421-6.1106. Hansen T, Corbet A. Neonatal pneumonias. In Avery´s Diseases of the Newborn 7 th Ed. Taeusch HW,Ballard RA Ed.WB Saunders Company, Philadelphia, 19981107. Misra S, Bhakoo ON, Ayyagiri A, Katariya S. Clinical & bacteriological profile of neonatal pneumonia.Indian J Med Res. 1991 Nov;93:366-70.1108. Szarka K, Temesvari P, Kerekes A, Tege A, Repkeny A. Neonatal pneumonia caused by Trichomonasvaginalis. Acta Microbiol Immunol Hung. 2002;49(1):15-9.1109. Webber S, Wilkinson AR, Lindsell D, Hope PL, Dobson SR, Isaacs D. Neonatal pneumonia. Arch DisChild. 1990 Feb;65(2):207-11.1110. Waites KB, Crouse DT, Philips JB 3rd, Canupp KC, Cassell GH. Ureaplasmal pneumonia and sepsisassociated with persistent pulmonary hypertension of the newborn. Pediatrics. 1989 Jan;83(1):79-85.Taquipnea transitoria1111. Avery ME.Transient tachypnea of the newborn infant. Am J Dis Child 1966;111:3801112. Bucciarelli RL, et al. Persistence of fetal cardiopulmonary circulation: one manifestation of transienttachypnea of the newborn Pediatrics 1976;28:1921113. Cerezo R. Taquipnea transitoria del recién nacido. En Medicina Neonatal 2ª Ed. Cerezo R, Figueroa REds. Librerías Paris, Guatemala 1994. pp 305-6 155MANUAL CLÍNICO AIEPI NEONATAL